Davidson Capital Management Inc. Halozyme Therapeutics, Inc. Transaction History
Davidson Capital Management Inc.
- $365 Million
- Q1 2025
A detailed history of Davidson Capital Management Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Davidson Capital Management Inc. holds 61,218 shares of HALO stock, worth $3.3 Million. This represents 1.07% of its overall portfolio holdings.
Number of Shares
61,218
Previous 56,639
8.08%
Holding current value
$3.3 Million
Previous $2.71 Million
44.29%
% of portfolio
1.07%
Previous 0.72%
Shares
5 transactions
Others Institutions Holding HALO
# of Institutions
594Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$950 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$692 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$326 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$210 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$198 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.51B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...